Pfizer ’ s five point plan

Responding to the global outbreak of COVID-19 , Pfizer released a fivepoint plan . The plan called on the biopharmaceutical industry to join its commitment to unprecedented collaboration in order to battle COVID-19 .

Pfizer and BionTech co-develop vaccine

Pfizer and BionTech agreed to a letter of intent for the co-development and distribution of a potential mRNAbased coronavirus vaccine to prevent the infection of COVID-19

Pfizer advances the battle against COVID-19

To further advance the battle against COVID-19 , Pfizer Inc . and the Pfizer Foundation pledged US $ 40mn in medical and charitable cash grants to combat the global health effects of the pandemic .

Pfizer and BionTech begin human trials

As part of the global COVID-19 vaccine development programme , Pfizer and BionTech began human trials on May 14 , 2020 . The first participants were dosed in the US in a clinical trial for the BNT162 vaccine programme .

20 April 2021